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Background: Cellular heterogeneity is present in almost all gene expression profiles. However, transcriptome
analysis of tissue specimens often ignores the cellular heterogeneity present in these samples. Standard
deconvolution algorithms require prior knowledge of the cell type frequencies within a tissue or their in vitro
expression profiles. Furthermore, these algorithms tend to report biased estimations.
Results: Here, we describe a Digital Sorting Algorithm (DSA) for extracting cell-type specific gene expression
profiles from mixed tissue samples that is unbiased and does not require prior knowledge of cell type frequencies.
Conclusions: The results suggest that DSA is a specific and sensitivity algorithm in gene expression profile
deconvolution and will be useful in studying individual cell types of complex tissues.Background
Cellular heterogeneity is present in nearly all biological
specimens. When the genome-wide transcriptional pro-
file of heterogeneous samples is measured under differ-
ent physiological states, any observed differences are
strongly confounded by differences in cell type composi-
tions between samples [1-3]. Recent studies suggest that
the microenvironment of a tissue may change under dif-
ferent physiological states and can contribute to the eti-
ology of diverse diseases [4-10]. Consequently, to fully
understand gene expression differences associated with
different physiological states, deconvolution of tissue ex-
pression into the component expression profiles of each
cell type is critically needed.
Fluorescence Activated Cell Sorting (FACS), Laser
Capture Micro-dissection (LCM) and Translating Ribo-
some Affinity Purification (TRAP) have been used to
physically separate defined cell types before gene expres-
sion analysis [2,11-13]. However, technical difficulties,
such as limited availability of good surface markers, cell
type specific promoters and transgenic models, have re-
stricted the application of these techniques. Further-
more, the sorting process may introduce additional* Correspondence: zhandong.liu@bcm.edu
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reproduction in any medium, provided the oristress on cells and hence alter their gene expression
profiles.
Unsupervised mixture models have been developed to
solve the gene expression devolution problem. For ex-
ample, a Latent Dirichlet Allocation (LDA) model
trained with a variational expectation maximization
framework was used to estimate the breast cancer cell
gene expression profiles from heterogeneous tumor sam-
ples [14]. An alternative approach [15] is to first reduce
the observed mixture using standard dimension reduc-
tion algorithm, such as principal components analysis
(PCA) or independent components analysis (ICA), find a
minimum-volume polytope with k vertices that enclose
the reduced data and then transform the reduced data
back to the gene expression profiles. The success appli-
cation of these unsupervised approaches will depend on
the availability of large number of observation over a
wide range of tissues [14,16]. In addition, these algo-
rithms do not use the biological knowledge on the cell
type markers.
Several supervised and semi-supervised computa-
tional deconvolution algorithms have also been pro-
posed to tackle this problem [17-21]. However, they
require prior knowledge of either the cell type frequen-
cies within a given tissue [19,20], or the in vitro gene
expression profiles of each component cell type [17,18].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
ginal work is properly cited.
Zhong et al. BMC Bioinformatics 2013, 14:89 Page 2 of 10
http://www.biomedcentral.com/1471-2105/14/89In reality, this information can be difficult to obtain
and presents a major roadblock for these kinds of ap-
proaches. Our previous work [22] has proved that gene
expression deconvolution should be done in linear
space rather than log-transformed space, as is often
used in microarray studies. Based on our previous find-
ings, we propose a novel Digital Sorting Algorithm
(DSA) that can deconvolve the expression of a tissue
into the component profiles of each cell type using a
set of marker genes that are highly expressed in each
cell type.Results and discussion
To test whether our proposed DSA algorithm can esti-
mate the cell type proportions in a mixed tissue or cell
population, we analyzed a benchmark dataset where
RNA from the liver, brain and lung of a rat were mixed
at 11 different proportions and the mixing parameters
are known. The gene expression of pure liver, brain, and
lung, and of the mixed samples, was measured using
Affymetrix expression arrays. DSA uses a set of gene
markers that are highly expressed in specific cell types
to estimate the cell type frequencies; the expression level
of these markers in pure cell types is not required. A list
of tissue-specific markers for the liver, brain and lung
was obtained from Tissue-specific Gene Expression and
Regulation (TIGER) [23] database and GENENOTE [24]
(Additional file 1: Table S1). Using these markers, we
were able to estimate the cell type frequencies for each
cell type from the mixtures (Figure 1a). Our results dem-
onstrate that DSA can accurately estimate the cell type
proportions using marker genes.
Next, we examined whether DSA can accurately
deconvolve the gene expression profile from mixed tis-
sue samples into tissue specific expression profiles.
Using the cell type frequencies we estimated using
marker genes, we were able to accurately estimate the
expression profiles of the liver, brain and lung cells that
constitute the mixture (Figure 1b-d). The deconvolved
expression was highly correlated with the true gene ex-
pression profile in each tissue type. The error measure
was smaller for genes that are highly expressed, as would
be predicted given that technical variations tend to have
larger impact for genes that are expressed at low levels.
The effect of the number of marker genes used in esti-
mating the proportion of each cell type was also studied.
We randomly sampled the marker genes from the
TIGER list (Additional file 1: Table S1). In 100 repeti-
tions, we plotted the correlation and mean absolute dif-
ference between the estimated and pure cell-specific
expressions against the number of markers used. Our re-
sults demonstrate that DSA is robust to the number of
marker genes and only requires several marker genes foraccurate gene expression deconvolution (Additional file 2:
Figure S1).
We next asked whether DSA can identify differentially
expressed genes between different tissue types. To do
this, we computed the gene expression fold change using
the deconvolved gene expression profile, and then car-
ried out a Receiver Operator Curve (ROC) analysis to
assess DSA’s ability to detect changes more than two-
fold between any tissue types. Our results demonstrate
that DSA is highly specific and sensitive in identifying
differentially expressed genes (Figure 1e-f ).
In the benchmark data, liver, brain and lung were used
to construct the mixtures. However, the expression dif-
ferences between different cell types within a tissue sam-
ple are much smaller compared to the differences
between liver, brain and lung. Hence, we tested whether
our DSA algorithm works on real tissue samples com-
posed of cell types with gene expression profiles that are
more similar to each other.
IM-9, Raji, Jurkat and THP-1 cells were mixed in dif-
ferent proportions and the expression profile of each
mixture was measured by microarray [19]. Marker genes
for each of the cell types was extracted from the Immu-
nogenetic Related Information Source (IRIS) database
[25]. First, we used the genes that are highly expressed
in each of these cells (Additional file 3: Table S2) to esti-
mate the cell type proportions accurately (Figure 2a).
Next, using the estimated cell type frequencies, we
deconvolved the expression profiles of the mixture into
profiles for each individual cell type (Figure 2b and
Additional file 4: Figure S2). Finally, to test whether the
estimated expression profiles of immune cells can be used
to identify genes that are differentially expressed between
cell types, we applied an ROC analysis on our decon-
volved expression profiles (Figure 2c and Additional file 5:
Figure S3). High AUC values (0.8 or higher) were ob-
served, indicating that differentially expressed genes
can be identified accurately with high specificity and
sensitivity.
Population specific expression analysis (PSEA) [26] is
an algorithm that has the same input parameters as
DSA. However, PSEA uses the marker gene information
as normalization factors in the gene expression deconvo-
lution analysis. Hence, the estimated gene expression
profiles are not the absolute gene expression values, but
are relative to the average of the marker genes for each
cell type. In practice, the marker genes from different
cells are not guaranteed to have the same expression
level. This critical assumption of PSEA makes compar-
ing results between different cell types biased towards
the marker gene expression.
To compare the performance of DSA and PSEA, we
tested both algorithms on the liver-brain-lung benchmark
dataset. The fold change differences estimated by DSA are
Figure 1 Unbiased estimation of tissue type specific profiles. (a) Mixing proportions were estimated using markers for liver, brain and lung.
DSA estimation can recapitulate the true percentage of each cell type in the mixture. (b-d) DSA estimation of liver, brain and lung gene
expression profiles compared against true expression profiles measured using pure tissue samples. (e-f) ROC analysis on differential gene
expression analysis of brain vs. liver and lung vs. liver using DSA.
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However, the fold change differences estimated by PSEA
between liver and brain are all negative, due to the fact
that the marker genes of liver are expressed at higher
levels than the markers genes of brain (Figure 3b). Our re-
sults demonstrate that the fold change estimated by DSA
is more accurate than PSEA. Since DSA only assumes that
marker genes are highly expressed and does not require
the marker genes to be expressed at same level, DSA tendsto estimate the absolute expression level as measured by
the array on pure cell populations.
We were next interested in determining the lower
limit of cell type frequency that could be estimated from
a mixed tissue. To test this, we simulated blood samples
using 6 different immune cell types with cell type
proportions ranging from 60% to 0.1% (Figure 4 and
Additional file 6: Table S3). Cells that are present at a
frequency greater than 10% in the tissue sample could
Figure 2 Unbiased estimation of cell type specific profiles. (a) Cell type frequencies were estimated using markers for IM-9 cells (green), Raji
cells (blue), Jurkat cells (red), and THP-1 cells (purple). (b) DSA estimation of the gene expression profiles of IM-9 cells compared against true
expression profiles measured using pure cell samples. (c) ROC analysis on differential gene expression analysis of estimated IM-9 cells vs. Jurkat
cells using DSA.
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present at greater than 1% but less than 10% can still be
estimated, though with relatively larger errors (Figure 4d-e).
Cell types that are present at lower than 1% in the tissue
failed to be identified (Figure 4f). To summarize our resultsFigure 3 Comparison between DSA and PSEA. (a) Fold change estimate
brain samples. The dotted line represents the reference line where all the p
against the true fold change between liver and brain samples.systematically, we plotted the error of estimation and fre-
quencies of each cell type against the signal to noise ratio
(SNR). Clearly, SNR decreases as cell type frequency goes
down, and the mean square of errors (MSE) goes up with
decreasing SNR (Figure 5d). To assess the sensitivity andd by DSA compared against the true fold change between liver and




Figure 4 (See legend on next page.)
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Figure 4 The estimated transcriptomes for 6 different immune cell types were plotted against the gene expression measured on
arrays. Cell types that have higher percentage in the tissue sample tend to have better estimation accuracy. (a-f) Scatter plots of estimated
profile against microarray measures in Eosinophil, Myeloid Dendritic, Mature B-cells, Granulocyte, Naïve B-cells, and Basophils.
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analysis on deconvolved expression profiles and found that
samples with high accuracy in deconvolution have high
AUC value. For samples that have low frequencies in a tis-
sue and poor accuracy in deconvolution, differential gene
analysis can still identify genes that are significantlyFigure 5 (a-c) The AUC analysis of cell types that have high and low c
myeloid dendritic cells have the best AUC scores since these two cell type
basophils yield poor but still informative AUC scores, as these two cell type
mean square of error (MSE) and weight against signal-to-noise ratio (SNR).
present at too low of a frequency in a given tissue will have dramatically inchanged between cell types with reasonable -- but signifi-
cantly reduced -- sensitivity and specificity (Figure 5a-c).
We next tested whether DSA is capable of estimating
the frequency of a cell type in a mixed tissue in vivo, and
subsequently obtaining its gene expression profile. To
this end, we applied our algorithm on a set of humanonfidence of deconvolved gene expression profile. Eosinophil and
s have the highest proportions in the mixed samples. Naïve B-cells and
s have the lowest frequency in the mixed samples. (d) The plot of
The best cut-off point was observed around 45. Cell types that are
creased errors.
Figure 6 (a) The percentage of TAMs in Hodgkin’s lymphoma tumors was negatively associated with progression-free survival.
(b) Genes that are highly expressed in DSA extracted TAMs are enriched for biological processes characteristic of macrophages, such as response
to wounding, immune, inflammatory and defense response.
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was shown to predict progression-free survival [8]. A set
of tumor associated macrophage (TAM) specific genes
was selected by comparing mouse mammary tumor as-
sociated macrophages to normal mouse splenic macro-
phages [9] (Additional file 7: Table S4). Using these
TAM-specific genes, DSA was applied to the gene ex-
pression profiles of a set of Hodgkin’s lymphomas. For each
tumor, DSA was able to estimate the percentage of TAMs
in the sample. We found that the estimated TAM percent-
age is a predictor of progression free survival for these pa-
tients (Figure 6a). A 30-fold lower p-value was achieved
using our estimation than using CD68 as a marker for
TAMs. The hazard ratio between TAM high and TAM
low group is 2.7. Using DSA, we were able to obtain
the gene expression profile of TAMs in the patient
samples. By comparing the TAM transcriptome to the
tumor transcriptome, we identified a list of genes that
are highly expressed in TAMs. When Gene Ontology
(GO) analysis was applied to these genes [10], we
identified response to wounding, defense response, and
inflammatory response as high significantly enriched
biological processes (Figure 6b). These results con-
firmed that the estimated gene expression profile is in-
deed enriched for macrophage related functions.
Conclusions
In conclusion, we have demonstrated the general feasi-
bility of a Digital Sorting Algorithm (DSA) to obtain cell
type specific gene expression profiles from a complex
tissue. DSA represents a dramatic improvement over the
conventional deconvolution approaches, which typically
require prior knowledge of cell type frequencies or
in vitro gene expression profiles for each cell type. By
using cell type specific genes, DSA overcomes these lim-
itations. We have also demonstrated that DSA is an
unbiased estimation algorithm for signal reconstruction
and deconvolution. Downstream analysis, such as differ-
ential gene analysis, will benefit from digital sorting
and yield better results. Most important of all, we have
demonstrated that DSA can be used to extract theexpression profile of a specific cell type from a complex
tissue. This will allow for investigation of the properties
of specific cell types in mixed tissues in vivo. For ex-
ample, we can obtain the gene expression profile of a
particular cell type in the cancer microenvironment just
from microarray data from the bulk tumor. In principle,
the DSA framework could be applied to any unbiased
high-throughput dataset, such as global DNA methyla-
tion array, next generation sequencing data, metabolic
data, and proteomics. Partially, RNA-seq is a more ac-
curate technology compared to microarray. The linearity
assumption holds true in RNA-seq studies, hence we be-
lieve that our DSA framework can also be applied to
RNA-seq data.
In many real-world applications, a small number of
cell type specific markers are often available to molecu-
lar biologists since these markers are frequently used in
biochemical assays. For example, the cancer stem cell
markers are known for many types of tumors. The use
of these markers in gene expression deconvolution
greatly improved the performance and also enabled the
application of this algorithm not only to cancer studies,
but also to other biological studies involved with hetero-
geneous samples.
DSA is implemented in a single R package (https://github.
com/zhandong/DSA). The package also includes sample
data from liver, brain and lung benchmark data and the
cell type specific markers.Methods
Microarray analysis
Liver, brain and lung tissues derived from a single rat
were homogenized, extracted, and mixed in 11 different
proportions in triplicates. The gene expression profile of
these mixed tissues were measured using Affymetrix
array and can be obtained from GSE19830. Immune cell
expression profiles were obtained from GSE11057 and
GSE24759. Hodgkin’s lymphoma dataset was obtained
from GSE17920. The tumor associated macrophage
marker genes were obtained from GSE18404.
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Six different immune cell lines that were used to con-
struct references are available in the simulated blood
samples. The weights were sampled randomly in de-
creasing order (Additional file 6: Table S3).
Linear model on gene expression deconvolution
Let S be an n × k gene expression matrix that contains k
cell types and n genes, W be a k × p matrix where each
column of W contains the frequencies of k cell types in
a particular observation, and O be an n × p expression
matrix that contains the observed gene expression level,
where n represents the number of genes and p is the
number of observed tissue samples. The mixing process
can be modeled through a linear model:
O ¼ S W ð1Þ
where S represents the source signal, W is the weight
matrix for cell type frequencies, and O is the observation
on tissue samples. In a typical gene expression profiling
setting, O is often measured through microarray or
RNA-seq. Both W and S are unknown and our goal is to
estimate S. We approach this problem by first estimating
W using cell type specific markers and then solve the
linear model using estimated W.
Estimate cell type frequencies matrix W from marker
genes
Given that we know a set of genes that has high expres-
sion level in a specific cell type and low expression in all
other cell types, we can predict the proportion of each
cell type present in the tissue sample using these genes.
Let XS be an m × k matrix that contains m cell type spe-
cific genes for k cell types. For each cell type, there could
be multiple cell type specific genes. Since each gene is
highly expressed in a single cell type, we can take an
average of all the genes that are highly expressed in a
single cell type and save the matrix as eXS .
XS ¼
g11 0 … 0
g21 0 … 0
0 g32 … 0
0 g42 … 0
0 g52 … 0
0 0 ⋱ ⋮







g1 0 … 0
0 g2 … 0
0 0 ⋱ 0





Although eXS is unknown, the corresponding gene ex-
pression for cell type specific markers, OS and ÕS aremeasured on the observed mixed samples. Substitute eXS
and ÕS to equation (1), we obtain
eOs ¼ eXS W ð2Þ
Since eXS is a diagonal matrix, we can multiply each
side of equation (2) by the eX1S and obtain
eX1S eOs ¼W ð3Þ
Given that W is the frequency matrix and each column
of W sums to 1 [15], we can form a system of linear







When the number of observations on the mixed samples
is greater the number of cell types involved that is p > k,
we can solve the system of equations with k unknown pa-
rameters. Once g1…gk is known, we can take eX1S into
equation (3) and compute the cell type frequency matrix.
Digital sorting on tissue samples
Input: Expression data on tissue samples and a set of
gene symbols that is known to be highly expressed in a
specific cell type.
Output: Expression profile for each of the cell types in
a tissue.
Step I: If W is known, proceed to step II, else estimate
W using XS and equation 3.
Step II: Estimate S through quadratic programming.
minS ‖O SW‖2
s:t S≺t1 and S  t2
where O is the gene expression profile on tissue samples,
S is the expression profile for pure cell types, W is the
weight matrix estimated using the marker genes, and t1
and t2 is the maximum and minimum measurable gene
expression level. R package ‘quadprog’ is used to solve
the quadratic programming problem.
Receiver operator characteristic (ROC) analysis
R package ‘ROCR’ from CRAN [27] was used to compute
the ROC curve and the area under curve (AUC). Specific-
ally, genes with more than 2 fold increase or decrease are
included in the reference list as the positive set. Our goal
is to assess the true positive rate and false positive rate in
identifying these genes using our estimated gene expres-
sion profiles. A ratio between the estimated gene expres-
sion profiles of two different cell types is used to compute
the ROC curve. A gene is classified into the positive set if
the ratio of this gene is greater than a threshold t. A ROC
curve is generated by varying t.
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Five tumor associated macrophage (TAM) marker genes
were selected by comparing the macrophage in mouse
mammary tumor to the normal splenic macrophages.
The percentage and expression profile of TAMs were es-
timated using DSA algorithm. A cox proportional hazard
model was used and a significant association was identi-
fied with survival. Further, patients are dichotomized
into two groups by comparing to the median percentage
of TAMs. A log rank test was calculated on these data.Additional files
Additional file 1: Table S1. Marker genes for liver, brain and lung
Additional file 2: Figure S1. Correlation and mean absolute difference
between DSA estimation and original cell specific expression using
various number of marker genes. The experiment was repeated 100
times on each number of marker genes. Result show that DSA was
robust to the number of marker genes used, even with small number of
marker genes.
Additional file 3: Table S2. Marker genes for cells of the immune
system.
Additional file 4: Figure S2. DSA estimation of T-cells, B-cells, and
monocytes. Cell type specific markers were extracted from Immune
Response In Silico database. Using these markers, DSA was able to
faithfully identify the gene expression profile of B-cells, T-cells, and
monocytes from mixture samples.
Additional file 5: Figure S3. AUC analysis for differential gene analysis.
Differential gene expression analysis using estimated pure cell gene
expression profiles was able to accurately identify genes that are
differentially expressed between different cell types.
Additional file 6: Table S3. Cell type proportions for simulated blood
samples.
Additional file 7: Table S4. Marker genes for Macrophages.Competing interests
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